Innovating the way we see and treat cancer

We are focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need.

Our technology

The unique potential of Radiopharmaceuticals in treating oncological diseases.

Learn more

Our pipeline

The unique potential of being First to Market or Best in Class.

Learn more

Our team

We have a unique commitment to improve patients’ hope in fighting cancer.

Learn more

Information for investors

Stock price, Company governance & updates from our multiple development programs.

Learn more

Latest news

ASX Releases

Bioshares Summit 2022 Presentation

May 12, 2022

Read moreRead more

Media Coverage

Radiopharm Theranostics panel discusses latest progress and understanding of the radiopharmaceutical sector

May 9, 2022

Read moreRead more

Media Coverage

Radiopharm continues strong progress and recognition of AVβ6-Integrin in Europe

May 6, 2022

Read moreRead more